284 related articles for article (PubMed ID: 30767212)
1. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
[TBL] [Abstract][Full Text] [Related]
2. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus.
Wirestam L; Saleh M; Svensson C; Compagno M; Zachrisson H; Wetterö J; Sjöwall C
Lupus; 2021 Jul; 30(8):1244-1253. PubMed ID: 33957796
[TBL] [Abstract][Full Text] [Related]
3. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
4. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.
Ajeganova S; Gustafsson T; Lindberg L; Hafström I; Frostegård J
Lupus Sci Med; 2020; 7(1):e000362. PubMed ID: 32095248
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Atherosclerosis in Sle Patients by Measuring Carotid Intima Media Thickness: A Cross Sectional Study.
Mukherjee R; Bhattacharya R; Naiya SB; Mondal SS; Lyngdoh L
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443433
[TBL] [Abstract][Full Text] [Related]
6. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Levy DM; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed A;
Arthritis Rheum; 2009 May; 60(5):1496-507. PubMed ID: 19404953
[TBL] [Abstract][Full Text] [Related]
7. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
Ajeganova S; Hafström I; Frostegård J
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
[TBL] [Abstract][Full Text] [Related]
9. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus.
Belibou C; Ancuţa C; Ancuţa E; Filoş C; Chirieac R
Rom J Morphol Embryol; 2012; 53(1):29-34. PubMed ID: 22395496
[TBL] [Abstract][Full Text] [Related]
10. Carotid intima-media thickness and arterial stiffness in pediatric systemic lupus erythematosus.
Su-Angka N; Khositseth A; Vilaiyuk S; Tangnararatchakit K; Prangwatanagul W
Lupus; 2017 Aug; 26(9):989-995. PubMed ID: 28420050
[TBL] [Abstract][Full Text] [Related]
11. B-cell activating factor and A proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients.
Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N
Am J Med Sci; 2022 Nov; 364(5):646-654. PubMed ID: 35580639
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis.
Sánchez-Pérez H; Tejera-Segura B; de Vera-González A; González-Delgado A; Olmos JM; Hernández JL; Corrales A; López-Mejías R; González-Gay MA; Ferraz-Amaro I
Clin Exp Rheumatol; 2017; 35(6):885-892. PubMed ID: 28281456
[TBL] [Abstract][Full Text] [Related]
13. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
Wu GC; Liu HR; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
Autoimmun Rev; 2016 Jan; 15(1):22-37. PubMed ID: 26455562
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
16. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
[TBL] [Abstract][Full Text] [Related]
18. Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus.
Medeiros PBS; Salomão RG; Teixeira SR; Rassi DM; Rodrigues L; Aragon DC; Fassini PG; Ued FV; Tostes RC; Monteiro JP; Ferriani VPL; de Carvalho LM
Pediatr Rheumatol Online J; 2021 Mar; 19(1):35. PubMed ID: 33743717
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
[TBL] [Abstract][Full Text] [Related]
20. Early Vascular Aging in Normotensive Patients With Systemic Lupus Erythematosus: Comparison With Young Patients Having Hypertension.
Morreale M; Mulè G; Ferrante A; D'ignoto F; Cottone S
Angiology; 2016 Aug; 67(7):676-82. PubMed ID: 26535012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]